Thoughts and information about the latest news in the world of migraine, cluster headache and other headache treatment around the world.
Posts tagged as:
If you’re still trying to sort through the Cox-2 maze, you’re not alone. What’s safe to take and what isn’t? What’s worth the risk? Are there alternatives? What should I take for what? There’s a good overview of the current situation in the USA by Dr Eric Matteson, a Mayo Clinic specialist. Even if you [...]
{ 0 comments }
Today the US Food and Drug Administration announced that Bextra (valdexocib) would be removed from the market, because the health risks outweigh the benefits. Others, such as Canadian and European governments are also asking for Bextra to be taken off the shelves. As I heard on the radio this morning, part of the issue is [...]
{ 0 comments }
I hate to bring up the topic of Cox-2 inhibitors one more time, but I did want to let you know in brief what has been happening. In various places in the world, the judgment has been much the same. For example, Europe and the USA seem to be both deciding to allow Cox-2 inhibitors [...]
{ 0 comments }
Yesterday two new studies were released on the Cox-2 class of drugs. Both studies involved Cox-2 drugs taken in combination with other treatments. They found in both cases that there were cardiovascular problems, including a worsening of hardening of the arteries (in mice) and an increased occurrence of heart attack and stroke (in humans). When [...]
{ 0 comments }
Yesterday the American FDA issued a health advisory regarding the drugs Cox-2 drugs Bextra and Celebrex, and the NSAID naproxen. Basically, they’re recommending that caution should be exercised with the drugs Bextra and Celebrex. Recent studies seem to indicate that they may increase the risk of heart attack and stroke. There is also concern about [...]
{ 0 comments }
Loading ...
